Avanos Medical (AVNS) Interest Coverage Ratio (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 350.93% |
| Dec 31, 2025 | 2,268.42% |
| Sep 30, 2025 | 100.15% |
| Jun 30, 2025 | -859.47% |
| Mar 31, 2025 | 103.28% |
| Dec 31, 2024 | -4,085.71% |
| Sep 30, 2024 | 84.52% |
| Jun 30, 2024 | 57.50% |
| Mar 31, 2024 | -61.98% |
| Dec 31, 2023 | 1,229.29% |
| Sep 30, 2023 | 142.55% |
| Jun 30, 2023 | 65.57% |
| Mar 31, 2023 | -131.50% |
| Dec 31, 2022 | 29.69% |
| Sep 30, 2022 | 14.06% |
| Jun 30, 2022 | -43.45% |
| Mar 31, 2022 | 120.67% |
| Dec 31, 2021 | -947.06% |
| Sep 30, 2021 | 146.58% |
| Jun 30, 2021 | 47.67% |
| Mar 31, 2021 | 11.33% |
| Dec 31, 2020 | -75,070.37% |
| Sep 30, 2020 | 94.44% |
| Jun 30, 2020 | -400.00% |
| Mar 31, 2020 | 118.75% |
| Dec 31, 2019 | 85.61% |
| Sep 30, 2019 | -84.69% |
| Jun 30, 2019 | 57.89% |
| Mar 31, 2019 | -180.36% |
| Dec 31, 2018 | -242.29% |
| Sep 30, 2018 | 87.50% |
| Jun 30, 2018 | 211.75% |
| Mar 31, 2018 | -114.77% |
| Dec 31, 2017 | 71.15% |
| Sep 30, 2017 | 17.23% |
| Jun 30, 2017 | 33.01% |
| Mar 31, 2017 | 89.63% |
| Dec 31, 2016 | -997.78% |
| Sep 30, 2016 | 17.34% |
| Jun 30, 2016 | -48.75% |
| Mar 31, 2016 | -87.23% |
| Dec 31, 2015 | 154.81% |
| Sep 30, 2015 | -2,481.18% |
| Jun 30, 2015 | -49.61% |
| Mar 31, 2015 | 21.14% |
| Dec 31, 2014 | -96.89% |